nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—skin cancer	0.586	1	CiPCiCtD
Capecitabine—DPYD—Fluorouracil—skin cancer	0.139	0.471	CbGbCtD
Capecitabine—TYMP—Fluorouracil—skin cancer	0.0922	0.313	CbGbCtD
Capecitabine—TYMS—Fluorouracil—skin cancer	0.0491	0.166	CbGbCtD
Capecitabine—CYP2C9—Vismodegib—skin cancer	0.0109	0.0371	CbGbCtD
Capecitabine—CYP2C9—Fluorouracil—skin cancer	0.00388	0.0132	CbGbCtD
Capecitabine—DPYD—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00185	0.135	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00165	0.121	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00132	0.0965	CbGpPWpGaD
Capecitabine—TYMP—endothelium—skin cancer	0.00123	0.0937	CbGeAlD
Capecitabine—TYMP—blood vessel—skin cancer	0.00113	0.0864	CbGeAlD
Capecitabine—CES1—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000972	0.0712	CbGpPWpGaD
Capecitabine—TYMP—nipple—skin cancer	0.000818	0.0624	CbGeAlD
Capecitabine—CDA—mammalian vulva—skin cancer	0.000793	0.0606	CbGeAlD
Capecitabine—TYMS—Sorafenib—Vismodegib—skin cancer	0.000739	0.584	CbGdCrCtD
Capecitabine—CDA—lymphoid tissue—skin cancer	0.000704	0.0538	CbGeAlD
Capecitabine—CES1—neck—skin cancer	0.000698	0.0533	CbGeAlD
Capecitabine—TYMS—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000675	0.0494	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000651	0.0477	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000581	0.0425	CbGpPWpGaD
Capecitabine—TYMP—connective tissue—skin cancer	0.00058	0.0443	CbGeAlD
Capecitabine—TYMS—Paclitaxel—Docetaxel—skin cancer	0.000527	0.416	CbGdCrCtD
Capecitabine—CES1—connective tissue—skin cancer	0.000501	0.0382	CbGeAlD
Capecitabine—TYMS—connective tissue—skin cancer	0.000497	0.038	CbGeAlD
Capecitabine—TYMP—mammalian vulva—skin cancer	0.000478	0.0365	CbGeAlD
Capecitabine—TYMP—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000464	0.034	CbGpPWpGaD
Capecitabine—TYMS—skin of body—skin cancer	0.000449	0.0343	CbGeAlD
Capecitabine—TYMP—lymphoid tissue—skin cancer	0.000424	0.0324	CbGeAlD
Capecitabine—DPYD—lymph node—skin cancer	0.000413	0.0315	CbGeAlD
Capecitabine—TYMS—mammalian vulva—skin cancer	0.00041	0.0313	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CDK4—skin cancer	0.000409	0.03	CbGpPWpGaD
Capecitabine—TYMP—female reproductive system—skin cancer	0.000409	0.0312	CbGeAlD
Capecitabine—CDA—lymph node—skin cancer	0.000397	0.0303	CbGeAlD
Capecitabine—CES1—E2F transcription factor network—XRCC1—skin cancer	0.000374	0.0274	CbGpPWpGaD
Capecitabine—CES1—lymphoid tissue—skin cancer	0.000366	0.028	CbGeAlD
Capecitabine—TYMS—lymphoid tissue—skin cancer	0.000364	0.0278	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—BRAF—skin cancer	0.000362	0.0265	CbGpPWpGaD
Capecitabine—CES1—female reproductive system—skin cancer	0.000353	0.027	CbGeAlD
Capecitabine—TYMS—female reproductive system—skin cancer	0.000351	0.0268	CbGeAlD
Capecitabine—CES1—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000342	0.025	CbGpPWpGaD
Capecitabine—TYMP—head—skin cancer	0.000342	0.0261	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CDKN2A—skin cancer	0.000313	0.0229	CbGpPWpGaD
Capecitabine—CES1—head—skin cancer	0.000295	0.0225	CbGeAlD
Capecitabine—TYMS—head—skin cancer	0.000293	0.0224	CbGeAlD
Capecitabine—TYMS—E2F transcription factor network—XRCC1—skin cancer	0.00026	0.019	CbGpPWpGaD
Capecitabine—TYMP—lymph node—skin cancer	0.000239	0.0183	CbGeAlD
Capecitabine—TYMS—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000237	0.0174	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—skin cancer	0.000232	0.017	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—skin cancer	0.000207	0.0152	CbGpPWpGaD
Capecitabine—CES1—lymph node—skin cancer	0.000206	0.0158	CbGeAlD
Capecitabine—TYMS—lymph node—skin cancer	0.000205	0.0157	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—TP53—skin cancer	0.000174	0.0127	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NKX2-1—skin cancer	0.000167	0.0122	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—HRAS—skin cancer	0.000167	0.0122	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—skin cancer	0.000166	0.0121	CbGpPWpGaD
Capecitabine—CYP2C9—female reproductive system—skin cancer	0.000153	0.0117	CbGeAlD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—skin cancer	0.000122	0.00894	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—skin cancer	0.000116	0.00851	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.0001	0.00734	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	9.51e-05	0.00696	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PLIN2—skin cancer	9.34e-05	0.00684	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	9.17e-05	0.00671	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—skin cancer	8.47e-05	0.0062	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PLIN2—skin cancer	8.33e-05	0.0061	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—skin cancer	8.07e-05	0.0059	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CSPG4—skin cancer	7.53e-05	0.00551	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CSPG4—skin cancer	6.71e-05	0.00491	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PLIN2—skin cancer	6.66e-05	0.00487	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDK4—skin cancer	6.45e-05	0.00472	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CSPG4—skin cancer	5.37e-05	0.00393	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ENO2—skin cancer	5.12e-05	0.00375	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—skin cancer	4.93e-05	0.00361	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.89e-05	0.00358	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—CDK4—skin cancer	4.69e-05	0.00344	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ENO2—skin cancer	4.56e-05	0.00334	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MLH1—skin cancer	4.16e-05	0.00305	CbGpPWpGaD
Capecitabine—Orthostatic hypotension—Docetaxel—skin cancer	4.01e-05	0.00044	CcSEcCtD
Capecitabine—Abdominal pain upper—Docetaxel—skin cancer	4.01e-05	0.00044	CcSEcCtD
Capecitabine—Rash—Vemurafenib—skin cancer	4.01e-05	0.00044	CcSEcCtD
Capecitabine—Mental disorder—Temozolomide—skin cancer	4.01e-05	0.000439	CcSEcCtD
Capecitabine—Dermatitis—Vemurafenib—skin cancer	4e-05	0.000439	CcSEcCtD
Capecitabine—Hypersensitivity—Imiquimod—skin cancer	3.99e-05	0.000438	CcSEcCtD
Capecitabine—Headache—Vemurafenib—skin cancer	3.98e-05	0.000437	CcSEcCtD
Capecitabine—Erythema—Temozolomide—skin cancer	3.98e-05	0.000437	CcSEcCtD
Capecitabine—Malnutrition—Temozolomide—skin cancer	3.98e-05	0.000437	CcSEcCtD
Capecitabine—Breast disorder—Docetaxel—skin cancer	3.97e-05	0.000436	CcSEcCtD
Capecitabine—Discomfort—Bleomycin—skin cancer	3.97e-05	0.000435	CcSEcCtD
Capecitabine—Malaise—Dactinomycin—skin cancer	3.97e-05	0.000435	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Docetaxel—skin cancer	3.96e-05	0.000434	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Docetaxel—skin cancer	3.96e-05	0.000434	CcSEcCtD
Capecitabine—Leukopenia—Dactinomycin—skin cancer	3.94e-05	0.000432	CcSEcCtD
Capecitabine—Nasopharyngitis—Docetaxel—skin cancer	3.93e-05	0.000431	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—skin cancer	3.9e-05	0.00286	CbGpPWpGaD
Capecitabine—Dysgeusia—Temozolomide—skin cancer	3.9e-05	0.000427	CcSEcCtD
Capecitabine—Asthenia—Imiquimod—skin cancer	3.89e-05	0.000427	CcSEcCtD
Capecitabine—Confusional state—Bleomycin—skin cancer	3.88e-05	0.000426	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Docetaxel—skin cancer	3.88e-05	0.000425	CcSEcCtD
Capecitabine—Oedema—Bleomycin—skin cancer	3.85e-05	0.000422	CcSEcCtD
Capecitabine—Back pain—Temozolomide—skin cancer	3.85e-05	0.000422	CcSEcCtD
Capecitabine—Pruritus—Imiquimod—skin cancer	3.83e-05	0.000421	CcSEcCtD
Capecitabine—Infection—Bleomycin—skin cancer	3.83e-05	0.00042	CcSEcCtD
Capecitabine—Dysphagia—Docetaxel—skin cancer	3.8e-05	0.000417	CcSEcCtD
Capecitabine—Nausea—Vemurafenib—skin cancer	3.77e-05	0.000414	CcSEcCtD
Capecitabine—Thrombocytopenia—Bleomycin—skin cancer	3.77e-05	0.000414	CcSEcCtD
Capecitabine—Arrhythmia—Fluorouracil—skin cancer	3.76e-05	0.000413	CcSEcCtD
Capecitabine—Vision blurred—Temozolomide—skin cancer	3.75e-05	0.000411	CcSEcCtD
Capecitabine—Myalgia—Dactinomycin—skin cancer	3.75e-05	0.000411	CcSEcCtD
Capecitabine—Bronchospasm—Docetaxel—skin cancer	3.74e-05	0.00041	CcSEcCtD
Capecitabine—Tremor—Temozolomide—skin cancer	3.73e-05	0.000409	CcSEcCtD
Capecitabine—Alopecia—Fluorouracil—skin cancer	3.72e-05	0.000408	CcSEcCtD
Capecitabine—Diarrhoea—Imiquimod—skin cancer	3.71e-05	0.000407	CcSEcCtD
Capecitabine—Discomfort—Dactinomycin—skin cancer	3.7e-05	0.000406	CcSEcCtD
Capecitabine—Angina pectoris—Docetaxel—skin cancer	3.7e-05	0.000406	CcSEcCtD
Capecitabine—Ill-defined disorder—Temozolomide—skin cancer	3.69e-05	0.000405	CcSEcCtD
Capecitabine—Anaemia—Temozolomide—skin cancer	3.68e-05	0.000403	CcSEcCtD
Capecitabine—Anorexia—Bleomycin—skin cancer	3.67e-05	0.000403	CcSEcCtD
Capecitabine—Erythema—Fluorouracil—skin cancer	3.67e-05	0.000402	CcSEcCtD
Capecitabine—TYMP—Metabolism—ENO2—skin cancer	3.65e-05	0.00267	CbGpPWpGaD
Capecitabine—Pancytopenia—Docetaxel—skin cancer	3.61e-05	0.000396	CcSEcCtD
Capecitabine—Hypotension—Bleomycin—skin cancer	3.6e-05	0.000395	CcSEcCtD
Capecitabine—Oedema—Dactinomycin—skin cancer	3.59e-05	0.000394	CcSEcCtD
Capecitabine—Malaise—Temozolomide—skin cancer	3.59e-05	0.000394	CcSEcCtD
Capecitabine—Dizziness—Imiquimod—skin cancer	3.58e-05	0.000393	CcSEcCtD
Capecitabine—Vertigo—Temozolomide—skin cancer	3.58e-05	0.000392	CcSEcCtD
Capecitabine—Infection—Dactinomycin—skin cancer	3.57e-05	0.000391	CcSEcCtD
Capecitabine—Leukopenia—Temozolomide—skin cancer	3.56e-05	0.000391	CcSEcCtD
Capecitabine—Neutropenia—Docetaxel—skin cancer	3.55e-05	0.00039	CcSEcCtD
Capecitabine—Palpitations—Temozolomide—skin cancer	3.52e-05	0.000386	CcSEcCtD
Capecitabine—Thrombocytopenia—Dactinomycin—skin cancer	3.52e-05	0.000386	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Bleomycin—skin cancer	3.51e-05	0.000385	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	3.49e-05	0.00256	CbGpPWpGaD
Capecitabine—Cough—Temozolomide—skin cancer	3.47e-05	0.000381	CcSEcCtD
Capecitabine—Paraesthesia—Bleomycin—skin cancer	3.46e-05	0.000379	CcSEcCtD
Capecitabine—Weight increased—Docetaxel—skin cancer	3.46e-05	0.000379	CcSEcCtD
Capecitabine—Vision blurred—Fluorouracil—skin cancer	3.46e-05	0.000379	CcSEcCtD
Capecitabine—Vomiting—Imiquimod—skin cancer	3.45e-05	0.000378	CcSEcCtD
Capecitabine—Weight decreased—Docetaxel—skin cancer	3.44e-05	0.000377	CcSEcCtD
Capecitabine—Hypertension—Temozolomide—skin cancer	3.44e-05	0.000377	CcSEcCtD
Capecitabine—Dyspnoea—Bleomycin—skin cancer	3.43e-05	0.000377	CcSEcCtD
Capecitabine—Anorexia—Dactinomycin—skin cancer	3.42e-05	0.000375	CcSEcCtD
Capecitabine—Rash—Imiquimod—skin cancer	3.42e-05	0.000375	CcSEcCtD
Capecitabine—Dermatitis—Imiquimod—skin cancer	3.41e-05	0.000374	CcSEcCtD
Capecitabine—Pneumonia—Docetaxel—skin cancer	3.41e-05	0.000374	CcSEcCtD
Capecitabine—TYMS—Metabolism—PLIN2—skin cancer	3.41e-05	0.00249	CbGpPWpGaD
Capecitabine—Headache—Imiquimod—skin cancer	3.4e-05	0.000372	CcSEcCtD
Capecitabine—Anaemia—Fluorouracil—skin cancer	3.39e-05	0.000372	CcSEcCtD
Capecitabine—Arthralgia—Temozolomide—skin cancer	3.39e-05	0.000372	CcSEcCtD
Capecitabine—Myalgia—Temozolomide—skin cancer	3.39e-05	0.000372	CcSEcCtD
Capecitabine—Infestation—Docetaxel—skin cancer	3.39e-05	0.000371	CcSEcCtD
Capecitabine—Infestation NOS—Docetaxel—skin cancer	3.39e-05	0.000371	CcSEcCtD
Capecitabine—Anxiety—Temozolomide—skin cancer	3.38e-05	0.00037	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	3.36e-05	0.000369	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Docetaxel—skin cancer	3.36e-05	0.000368	CcSEcCtD
Capecitabine—Discomfort—Temozolomide—skin cancer	3.35e-05	0.000367	CcSEcCtD
Capecitabine—Decreased appetite—Bleomycin—skin cancer	3.35e-05	0.000367	CcSEcCtD
Capecitabine—Acute coronary syndrome—Docetaxel—skin cancer	3.34e-05	0.000366	CcSEcCtD
Capecitabine—Renal failure—Docetaxel—skin cancer	3.33e-05	0.000365	CcSEcCtD
Capecitabine—Myocardial infarction—Docetaxel—skin cancer	3.32e-05	0.000364	CcSEcCtD
Capecitabine—Neuropathy peripheral—Docetaxel—skin cancer	3.32e-05	0.000364	CcSEcCtD
Capecitabine—Dry mouth—Temozolomide—skin cancer	3.31e-05	0.000363	CcSEcCtD
Capecitabine—Jaundice—Docetaxel—skin cancer	3.3e-05	0.000362	CcSEcCtD
Capecitabine—Stomatitis—Docetaxel—skin cancer	3.3e-05	0.000362	CcSEcCtD
Capecitabine—Pain—Bleomycin—skin cancer	3.29e-05	0.000361	CcSEcCtD
Capecitabine—Conjunctivitis—Docetaxel—skin cancer	3.29e-05	0.000361	CcSEcCtD
Capecitabine—Leukopenia—Fluorouracil—skin cancer	3.28e-05	0.00036	CcSEcCtD
Capecitabine—Confusional state—Temozolomide—skin cancer	3.27e-05	0.000359	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Dactinomycin—skin cancer	3.27e-05	0.000359	CcSEcCtD
Capecitabine—Oedema—Temozolomide—skin cancer	3.25e-05	0.000356	CcSEcCtD
Capecitabine—Infection—Temozolomide—skin cancer	3.23e-05	0.000354	CcSEcCtD
Capecitabine—Nausea—Imiquimod—skin cancer	3.22e-05	0.000353	CcSEcCtD
Capecitabine—Hepatobiliary disease—Docetaxel—skin cancer	3.2e-05	0.000351	CcSEcCtD
Capecitabine—Epistaxis—Docetaxel—skin cancer	3.19e-05	0.00035	CcSEcCtD
Capecitabine—Nervous system disorder—Temozolomide—skin cancer	3.19e-05	0.000349	CcSEcCtD
Capecitabine—Thrombocytopenia—Temozolomide—skin cancer	3.18e-05	0.000349	CcSEcCtD
Capecitabine—Feeling abnormal—Bleomycin—skin cancer	3.17e-05	0.000348	CcSEcCtD
Capecitabine—Agranulocytosis—Docetaxel—skin cancer	3.16e-05	0.000347	CcSEcCtD
Capecitabine—Skin disorder—Temozolomide—skin cancer	3.15e-05	0.000346	CcSEcCtD
Capecitabine—Hyperhidrosis—Temozolomide—skin cancer	3.14e-05	0.000344	CcSEcCtD
Capecitabine—Chest pain—Fluorouracil—skin cancer	3.12e-05	0.000342	CcSEcCtD
Capecitabine—Myalgia—Fluorouracil—skin cancer	3.12e-05	0.000342	CcSEcCtD
Capecitabine—Decreased appetite—Dactinomycin—skin cancer	3.12e-05	0.000342	CcSEcCtD
Capecitabine—Fatigue—Dactinomycin—skin cancer	3.1e-05	0.00034	CcSEcCtD
Capecitabine—Anorexia—Temozolomide—skin cancer	3.1e-05	0.00034	CcSEcCtD
Capecitabine—Discomfort—Fluorouracil—skin cancer	3.08e-05	0.000338	CcSEcCtD
Capecitabine—Pain—Dactinomycin—skin cancer	3.07e-05	0.000337	CcSEcCtD
Capecitabine—Urticaria—Bleomycin—skin cancer	3.06e-05	0.000336	CcSEcCtD
Capecitabine—Haemoglobin—Docetaxel—skin cancer	3.06e-05	0.000335	CcSEcCtD
Capecitabine—Rhinitis—Docetaxel—skin cancer	3.05e-05	0.000334	CcSEcCtD
Capecitabine—Body temperature increased—Bleomycin—skin cancer	3.04e-05	0.000334	CcSEcCtD
Capecitabine—Haemorrhage—Docetaxel—skin cancer	3.04e-05	0.000333	CcSEcCtD
Capecitabine—Hepatitis—Docetaxel—skin cancer	3.04e-05	0.000333	CcSEcCtD
Capecitabine—Hypoaesthesia—Docetaxel—skin cancer	3.02e-05	0.000332	CcSEcCtD
Capecitabine—Confusional state—Fluorouracil—skin cancer	3.02e-05	0.000331	CcSEcCtD
Capecitabine—Pharyngitis—Docetaxel—skin cancer	3.02e-05	0.000331	CcSEcCtD
Capecitabine—Urinary tract disorder—Docetaxel—skin cancer	3e-05	0.000329	CcSEcCtD
Capecitabine—Oedema peripheral—Docetaxel—skin cancer	2.99e-05	0.000329	CcSEcCtD
Capecitabine—Oedema—Fluorouracil—skin cancer	2.99e-05	0.000328	CcSEcCtD
Capecitabine—Connective tissue disorder—Docetaxel—skin cancer	2.99e-05	0.000328	CcSEcCtD
Capecitabine—Urethral disorder—Docetaxel—skin cancer	2.98e-05	0.000327	CcSEcCtD
Capecitabine—DPYD—Metabolism—ERCC2—skin cancer	2.97e-05	0.00218	CbGpPWpGaD
Capecitabine—Infection—Fluorouracil—skin cancer	2.97e-05	0.000326	CcSEcCtD
Capecitabine—Feeling abnormal—Dactinomycin—skin cancer	2.96e-05	0.000325	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Temozolomide—skin cancer	2.96e-05	0.000325	CcSEcCtD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.94e-05	0.00215	CbGpPWpGaD
Capecitabine—Insomnia—Temozolomide—skin cancer	2.94e-05	0.000322	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dactinomycin—skin cancer	2.94e-05	0.000322	CcSEcCtD
Capecitabine—Nervous system disorder—Fluorouracil—skin cancer	2.93e-05	0.000322	CcSEcCtD
Capecitabine—Thrombocytopenia—Fluorouracil—skin cancer	2.93e-05	0.000321	CcSEcCtD
Capecitabine—Visual impairment—Docetaxel—skin cancer	2.93e-05	0.000321	CcSEcCtD
Capecitabine—Tachycardia—Fluorouracil—skin cancer	2.92e-05	0.00032	CcSEcCtD
Capecitabine—Paraesthesia—Temozolomide—skin cancer	2.92e-05	0.00032	CcSEcCtD
Capecitabine—Dyspnoea—Temozolomide—skin cancer	2.9e-05	0.000318	CcSEcCtD
Capecitabine—Erythema multiforme—Docetaxel—skin cancer	2.87e-05	0.000315	CcSEcCtD
Capecitabine—Dyspepsia—Temozolomide—skin cancer	2.86e-05	0.000314	CcSEcCtD
Capecitabine—Anorexia—Fluorouracil—skin cancer	2.85e-05	0.000313	CcSEcCtD
Capecitabine—Eye disorder—Docetaxel—skin cancer	2.84e-05	0.000312	CcSEcCtD
Capecitabine—Body temperature increased—Dactinomycin—skin cancer	2.84e-05	0.000311	CcSEcCtD
Capecitabine—Abdominal pain—Dactinomycin—skin cancer	2.84e-05	0.000311	CcSEcCtD
Capecitabine—Hypersensitivity—Bleomycin—skin cancer	2.84e-05	0.000311	CcSEcCtD
Capecitabine—Decreased appetite—Temozolomide—skin cancer	2.82e-05	0.00031	CcSEcCtD
Capecitabine—Cardiac disorder—Docetaxel—skin cancer	2.82e-05	0.000309	CcSEcCtD
Capecitabine—Flushing—Docetaxel—skin cancer	2.82e-05	0.000309	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Temozolomide—skin cancer	2.8e-05	0.000308	CcSEcCtD
Capecitabine—Fatigue—Temozolomide—skin cancer	2.8e-05	0.000307	CcSEcCtD
Capecitabine—Hypotension—Fluorouracil—skin cancer	2.8e-05	0.000307	CcSEcCtD
Capecitabine—Pain—Temozolomide—skin cancer	2.78e-05	0.000305	CcSEcCtD
Capecitabine—Constipation—Temozolomide—skin cancer	2.78e-05	0.000305	CcSEcCtD
Capecitabine—Asthenia—Bleomycin—skin cancer	2.76e-05	0.000303	CcSEcCtD
Capecitabine—Angiopathy—Docetaxel—skin cancer	2.76e-05	0.000303	CcSEcCtD
Capecitabine—Immune system disorder—Docetaxel—skin cancer	2.75e-05	0.000301	CcSEcCtD
Capecitabine—TYMS—Metabolism—CSPG4—skin cancer	2.74e-05	0.00201	CbGpPWpGaD
Capecitabine—Mediastinal disorder—Docetaxel—skin cancer	2.74e-05	0.000301	CcSEcCtD
Capecitabine—Chills—Docetaxel—skin cancer	2.73e-05	0.000299	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Fluorouracil—skin cancer	2.73e-05	0.000299	CcSEcCtD
Capecitabine—Pruritus—Bleomycin—skin cancer	2.72e-05	0.000299	CcSEcCtD
Capecitabine—Arrhythmia—Docetaxel—skin cancer	2.72e-05	0.000298	CcSEcCtD
Capecitabine—Insomnia—Fluorouracil—skin cancer	2.71e-05	0.000297	CcSEcCtD
Capecitabine—Paraesthesia—Fluorouracil—skin cancer	2.69e-05	0.000295	CcSEcCtD
Capecitabine—Alopecia—Docetaxel—skin cancer	2.69e-05	0.000295	CcSEcCtD
Capecitabine—Feeling abnormal—Temozolomide—skin cancer	2.68e-05	0.000294	CcSEcCtD
Capecitabine—Dyspnoea—Fluorouracil—skin cancer	2.67e-05	0.000293	CcSEcCtD
Capecitabine—Mental disorder—Docetaxel—skin cancer	2.66e-05	0.000292	CcSEcCtD
Capecitabine—Gastrointestinal pain—Temozolomide—skin cancer	2.66e-05	0.000291	CcSEcCtD
Capecitabine—CDA—Metabolism—ERCC2—skin cancer	2.65e-05	0.00194	CbGpPWpGaD
Capecitabine—Malnutrition—Docetaxel—skin cancer	2.65e-05	0.00029	CcSEcCtD
Capecitabine—Erythema—Docetaxel—skin cancer	2.65e-05	0.00029	CcSEcCtD
Capecitabine—Hypersensitivity—Dactinomycin—skin cancer	2.65e-05	0.00029	CcSEcCtD
Capecitabine—Dyspepsia—Fluorouracil—skin cancer	2.63e-05	0.000289	CcSEcCtD
Capecitabine—Decreased appetite—Fluorouracil—skin cancer	2.6e-05	0.000285	CcSEcCtD
Capecitabine—Dysgeusia—Docetaxel—skin cancer	2.59e-05	0.000284	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Fluorouracil—skin cancer	2.58e-05	0.000283	CcSEcCtD
Capecitabine—Urticaria—Temozolomide—skin cancer	2.58e-05	0.000283	CcSEcCtD
Capecitabine—Asthenia—Dactinomycin—skin cancer	2.58e-05	0.000283	CcSEcCtD
Capecitabine—Body temperature increased—Temozolomide—skin cancer	2.57e-05	0.000282	CcSEcCtD
Capecitabine—Abdominal pain—Temozolomide—skin cancer	2.57e-05	0.000282	CcSEcCtD
Capecitabine—Back pain—Docetaxel—skin cancer	2.56e-05	0.000281	CcSEcCtD
Capecitabine—Pain—Fluorouracil—skin cancer	2.56e-05	0.000281	CcSEcCtD
Capecitabine—Muscle spasms—Docetaxel—skin cancer	2.54e-05	0.000279	CcSEcCtD
Capecitabine—Feeling abnormal—Fluorouracil—skin cancer	2.47e-05	0.00027	CcSEcCtD
Capecitabine—Diarrhoea—Dactinomycin—skin cancer	2.46e-05	0.00027	CcSEcCtD
Capecitabine—Vomiting—Bleomycin—skin cancer	2.45e-05	0.000269	CcSEcCtD
Capecitabine—Anaemia—Docetaxel—skin cancer	2.45e-05	0.000268	CcSEcCtD
Capecitabine—Rash—Bleomycin—skin cancer	2.43e-05	0.000266	CcSEcCtD
Capecitabine—Dermatitis—Bleomycin—skin cancer	2.43e-05	0.000266	CcSEcCtD
Capecitabine—Hypersensitivity—Temozolomide—skin cancer	2.39e-05	0.000262	CcSEcCtD
Capecitabine—Urticaria—Fluorouracil—skin cancer	2.38e-05	0.000261	CcSEcCtD
Capecitabine—Syncope—Docetaxel—skin cancer	2.37e-05	0.00026	CcSEcCtD
Capecitabine—Leukopenia—Docetaxel—skin cancer	2.37e-05	0.00026	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK4—skin cancer	2.37e-05	0.00173	CbGpPWpGaD
Capecitabine—Body temperature increased—Fluorouracil—skin cancer	2.37e-05	0.000259	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TERT—skin cancer	2.36e-05	0.00173	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.34e-05	0.00171	CbGpPWpGaD
Capecitabine—Palpitations—Docetaxel—skin cancer	2.34e-05	0.000257	CcSEcCtD
Capecitabine—Asthenia—Temozolomide—skin cancer	2.33e-05	0.000256	CcSEcCtD
Capecitabine—Loss of consciousness—Docetaxel—skin cancer	2.33e-05	0.000255	CcSEcCtD
Capecitabine—Cough—Docetaxel—skin cancer	2.31e-05	0.000253	CcSEcCtD
Capecitabine—Pruritus—Temozolomide—skin cancer	2.3e-05	0.000252	CcSEcCtD
Capecitabine—Nausea—Bleomycin—skin cancer	2.29e-05	0.000251	CcSEcCtD
Capecitabine—Hypertension—Docetaxel—skin cancer	2.28e-05	0.000251	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—skin cancer	2.28e-05	0.00025	CcSEcCtD
Capecitabine—Rash—Dactinomycin—skin cancer	2.26e-05	0.000248	CcSEcCtD
Capecitabine—Chest pain—Docetaxel—skin cancer	2.25e-05	0.000247	CcSEcCtD
Capecitabine—Myalgia—Docetaxel—skin cancer	2.25e-05	0.000247	CcSEcCtD
Capecitabine—Arthralgia—Docetaxel—skin cancer	2.25e-05	0.000247	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	2.24e-05	0.000245	CcSEcCtD
Capecitabine—Diarrhoea—Temozolomide—skin cancer	2.22e-05	0.000244	CcSEcCtD
Capecitabine—Hypersensitivity—Fluorouracil—skin cancer	2.2e-05	0.000242	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.2e-05	0.00161	CbGpPWpGaD
Capecitabine—Dry mouth—Docetaxel—skin cancer	2.2e-05	0.000242	CcSEcCtD
Capecitabine—Confusional state—Docetaxel—skin cancer	2.18e-05	0.000239	CcSEcCtD
Capecitabine—Oedema—Docetaxel—skin cancer	2.16e-05	0.000237	CcSEcCtD
Capecitabine—Dizziness—Temozolomide—skin cancer	2.15e-05	0.000236	CcSEcCtD
Capecitabine—Infection—Docetaxel—skin cancer	2.15e-05	0.000235	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—skin cancer	2.13e-05	0.000234	CcSEcCtD
Capecitabine—Shock—Docetaxel—skin cancer	2.13e-05	0.000233	CcSEcCtD
Capecitabine—TYMP—Metabolism—ERCC2—skin cancer	2.12e-05	0.00155	CbGpPWpGaD
Capecitabine—Nervous system disorder—Docetaxel—skin cancer	2.12e-05	0.000232	CcSEcCtD
Capecitabine—Pruritus—Fluorouracil—skin cancer	2.12e-05	0.000232	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDK4—skin cancer	2.12e-05	0.00155	CbGpPWpGaD
Capecitabine—Thrombocytopenia—Docetaxel—skin cancer	2.11e-05	0.000232	CcSEcCtD
Capecitabine—Tachycardia—Docetaxel—skin cancer	2.11e-05	0.000231	CcSEcCtD
Capecitabine—Skin disorder—Docetaxel—skin cancer	2.1e-05	0.00023	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.08e-05	0.00152	CbGpPWpGaD
Capecitabine—Vomiting—Temozolomide—skin cancer	2.07e-05	0.000227	CcSEcCtD
Capecitabine—Anorexia—Docetaxel—skin cancer	2.06e-05	0.000226	CcSEcCtD
Capecitabine—Rash—Temozolomide—skin cancer	2.05e-05	0.000225	CcSEcCtD
Capecitabine—Diarrhoea—Fluorouracil—skin cancer	2.05e-05	0.000225	CcSEcCtD
Capecitabine—Dermatitis—Temozolomide—skin cancer	2.05e-05	0.000224	CcSEcCtD
Capecitabine—Headache—Temozolomide—skin cancer	2.03e-05	0.000223	CcSEcCtD
Capecitabine—Hypotension—Docetaxel—skin cancer	2.02e-05	0.000221	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—skin cancer	2e-05	0.00146	CbGpPWpGaD
Capecitabine—Dizziness—Fluorouracil—skin cancer	1.98e-05	0.000217	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Docetaxel—skin cancer	1.97e-05	0.000216	CcSEcCtD
Capecitabine—Insomnia—Docetaxel—skin cancer	1.95e-05	0.000214	CcSEcCtD
Capecitabine—Paraesthesia—Docetaxel—skin cancer	1.94e-05	0.000213	CcSEcCtD
Capecitabine—Nausea—Temozolomide—skin cancer	1.93e-05	0.000212	CcSEcCtD
Capecitabine—Dyspnoea—Docetaxel—skin cancer	1.93e-05	0.000211	CcSEcCtD
Capecitabine—Vomiting—Fluorouracil—skin cancer	1.9e-05	0.000209	CcSEcCtD
Capecitabine—Dyspepsia—Docetaxel—skin cancer	1.9e-05	0.000209	CcSEcCtD
Capecitabine—Rash—Fluorouracil—skin cancer	1.89e-05	0.000207	CcSEcCtD
Capecitabine—Dermatitis—Fluorouracil—skin cancer	1.89e-05	0.000207	CcSEcCtD
Capecitabine—Decreased appetite—Docetaxel—skin cancer	1.88e-05	0.000206	CcSEcCtD
Capecitabine—Headache—Fluorouracil—skin cancer	1.87e-05	0.000206	CcSEcCtD
Capecitabine—TYMS—Metabolism—ENO2—skin cancer	1.87e-05	0.00137	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Docetaxel—skin cancer	1.86e-05	0.000205	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—skin cancer	1.86e-05	0.000204	CcSEcCtD
Capecitabine—Constipation—Docetaxel—skin cancer	1.85e-05	0.000203	CcSEcCtD
Capecitabine—Pain—Docetaxel—skin cancer	1.85e-05	0.000203	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—IL6—skin cancer	1.83e-05	0.00134	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—skin cancer	1.81e-05	0.00132	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—skin cancer	1.78e-05	0.0013	CbGpPWpGaD
Capecitabine—Feeling abnormal—Docetaxel—skin cancer	1.78e-05	0.000195	CcSEcCtD
Capecitabine—Nausea—Fluorouracil—skin cancer	1.78e-05	0.000195	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—skin cancer	1.77e-05	0.000194	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—skin cancer	1.71e-05	0.000187	CcSEcCtD
Capecitabine—Abdominal pain—Docetaxel—skin cancer	1.71e-05	0.000187	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN2A—skin cancer	1.62e-05	0.00118	CbGpPWpGaD
Capecitabine—Hypersensitivity—Docetaxel—skin cancer	1.59e-05	0.000175	CcSEcCtD
Capecitabine—CDA—Metabolism—PTGS2—skin cancer	1.59e-05	0.00116	CbGpPWpGaD
Capecitabine—Asthenia—Docetaxel—skin cancer	1.55e-05	0.00017	CcSEcCtD
Capecitabine—Pruritus—Docetaxel—skin cancer	1.53e-05	0.000168	CcSEcCtD
Capecitabine—Diarrhoea—Docetaxel—skin cancer	1.48e-05	0.000162	CcSEcCtD
Capecitabine—Dizziness—Docetaxel—skin cancer	1.43e-05	0.000157	CcSEcCtD
Capecitabine—Vomiting—Docetaxel—skin cancer	1.37e-05	0.000151	CcSEcCtD
Capecitabine—Rash—Docetaxel—skin cancer	1.36e-05	0.000149	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—skin cancer	1.36e-05	0.000149	CcSEcCtD
Capecitabine—Headache—Docetaxel—skin cancer	1.35e-05	0.000148	CcSEcCtD
Capecitabine—Nausea—Docetaxel—skin cancer	1.28e-05	0.000141	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTGS2—skin cancer	1.27e-05	0.00093	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ERCC2—skin cancer	1.08e-05	0.000793	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLIN2—skin cancer	9.82e-06	0.000718	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—skin cancer	9e-06	0.000659	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CSPG4—skin cancer	7.91e-06	0.000579	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—skin cancer	6.5e-06	0.000476	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO2—skin cancer	5.38e-06	0.000394	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.21e-06	0.000308	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ERCC2—skin cancer	3.12e-06	0.000229	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—skin cancer	1.87e-06	0.000137	CbGpPWpGaD
